Loading...
BridgeBio Pharma, Inc.
BBIO•NASDAQ
Healthcare
Biotechnology
$46.48
$0.50(1.09%)
BridgeBio Pharma, Inc. (BBIO) Financial Performance & Statements
Review BridgeBio Pharma, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2285.27%
↑ 2285.27%
Operating Income Growth
2.37%
↑ 2.37%
Net Income Growth
16.70%
↑ 16.70%
Operating Cash Flow Growth
1.33%
↑ 1.33%
Operating Margin
-547.57%
↓ 547.57%
Gross Margin
96.95%
↑ 96.95%
Net Profit Margin
-524.25%
↓ 524.25%
ROE
49.21%
↑ 49.21%
ROIC
-95.63%
↓ 95.63%
BridgeBio Pharma, Inc. (BBIO) Financial Statements
Explore quarterly and annual reports for BridgeBio Pharma, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.88M | $2.73M | $2.17M | $211.12M |
| Cost of Revenue | $2.08M | $598000.00 | $598000.00 | $1.89M |
| Gross Profit | $3.80M | $2.13M | $1.57M | $209.23M |
| Gross Profit Ratio | $0.65 | $0.78 | $0.72 | $0.99 |
| R&D Expenses | $130.35M | $120.44M | $114.69M | $140.97M |
| SG&A Expenses | $94.78M | $68.82M | $59.52M | $64.51M |
| Operating Expenses | $229.82M | $193.88M | $177.11M | $205.48M |
| Total Costs & Expenses | $231.91M | $194.48M | $177.71M | $207.38M |
| Interest Income | $4.68M | $3.30M | $5.20M | $4.08M |
| Interest Expense | $29.82M | $23.06M | $22.94M | $23.47M |
| Depreciation & Amortization | $1.37M | $1.54M | $1.57M | $1.60M |
| EBITDA | -$235.05M | -$139.66M | -$51.03M | -$11.09M |
| EBITDA Ratio | -$39.96 | -$51.12 | -$23.54 | -$0.05 |
| Operating Income | -$226.03M | -$191.75M | -$175.54M | $3.74M |
| Operating Income Ratio | -$38.43 | -$70.19 | -$80.97 | $0.02 |
| Other Income/Expenses (Net) | -$40.21M | $27.50M | $100.00M | -$36.50M |
| Income Before Tax | -$266.24M | -$164.25M | -$75.54M | -$36.16M |
| Income Before Tax Ratio | -$45.26 | -$60.12 | -$34.85 | -$0.17 |
| Income Tax Expense | $1.15M | $0.00 | $0.00 | -$944000.00 |
| Net Income | -$265.05M | -$162.04M | -$73.46M | -$35.22M |
| Net Income Ratio | -$45.06 | -$59.31 | -$33.88 | -$0.17 |
| EPS | -$1.40 | -$0.86 | -$0.39 | -$0.20 |
| Diluted EPS | -$1.40 | -$0.86 | -$0.39 | -$0.20 |
| Weighted Avg Shares Outstanding | $189.44M | $188.51M | $187.59M | $178.71M |
| Weighted Avg Shares Outstanding (Diluted) | $189.44M | $188.51M | $187.59M | $178.71M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan